The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Yigal Arnon & Co

Work +972 3 608 7777
Fax +972 3 608 7724
Jerusalem, Tel Aviv, Tel Aviv

Daniel Green

Work +972 2 6239200
Yigal Arnon & Co

Work Department

Asia Practice Group, High-Tech, Life Sciences, Technology and Transactional IP, Venture Capital and Private Equity.


Daniel Green's practice focuses on licensing, corporate partnering and intellectual property. Daniel has represented emerging and established technology companies in the information technology, e-commerce, biotechnology, medical device and pharmaceutical industries. Daniel has extensive experience in structuring, negotiating and documenting complex licensing, development and technology transfer arrangements, Internet and e-commerce agreements, OEM, VAR and other distribution and supply arrangements, joint ventures and other commercial transactions. Daniel also advises venture capital funds and has been involved with secondary fund transactions and various aspects of fund formation.


Prior to joining Yigal Arnon & Co., Daniel practiced law in Toronto, Canada, for a number of years with Cassels Brock & Blackwell LLP. Daniel has been a guest lecturer at the Hebrew University Law School in Jerusalem and at a continuing education program sponsored by the Israel Bar, and has been published in a leading international intellectual property periodical. Daniel joined the firm in 2003 and became a partner in 2012.


Daniel is fluent in English, Hebrew and French.


Daniel was admitted to the Law Society of Upper Canada (Ontario) in 1998 and to the Israel Bar in 2003.


Daniel earned his law degree at Osgoode Hall Law School of York University in Toronto. He also holds a B.A.(hon.) in Political Science from McGill University in Montreal and an M.A. (magna cum laude) in Middle East History from Tel Aviv University.


Healthcare and life sciences

Within: Healthcare and life sciences

Yigal Arnon & Co brings together a very strong corporate practice and a highly specialised IP team to advise clients in the pharmaceutical, medical device and biotech sectors on a range of IP matters, inbound and outbound licensing, and complex M&A and cross-border investment transactions. Yoheved Novogroder-Shoshan advises FutuRx, a joint venture comprising Johnson & Johnson, Takeda and Orbimed, on pharmaceutical licensing transactions with universities and research institutions worldwide. Novogroder-Shoshan also assisted Alyn Hospital with the establishment of its Innovation Space. Also of note, Barry Levenfeld assisted with the formation of MEDX XELERATOR, a state-sponsored medical devices incubator, and provides the client with ongoing advice regarding commercialisation and arrangements among its partners and investors. Moreover, the firm's corporate team has been involved in a number of cross-border transactions in the biotech and healthcare sectors, which included acting for SteadyMed, the target company, in a reverse triangular merger with United Therapeutics Corporation. Other key figures include Daniel Green and Eli Greenbaum.

[back to top]

Intellectual property: commercial/transactions

Within: Intellectual property: commercial/transactions

Yigal Arnon & Co has strengths across the spectrum of commercial IP transactions, from domestic and international licensing deals to IP-driven M&A in a huge range of sectors, including fintech, medtech, telecoms and big data. Two key figures in the team are Yoheved Novogroder-Shoshan and Barry Levenfeld, who have assisted FutuRx with a number of commercial agreements, including licensing deals with universities in Germany, the US and South Korea. Novogroder-Shoshan also advised Oculis, a Novartis Venture Fund portfolio company, on licensing agreements with two academic institutions in Iceland. Also recommended is Daniel Green, who is acting for iPharma (Hong Kong), a joint venture formed by BioLineRx and a Chinese investor, in relation to an in-licensing transaction with Boehringer Ingelheim International. The team also has expertise in open source software and semiconductors, and Eli Greenbaum handles a range of commercial IP work for clients such as Autotalks. Further, Greenbaum has advised Minute on commercial IP deals with US sporting bodies, including NFL, MLB, NBA and PGA.

[back to top]

IHL Briefings

If your firm wishes to publish IHL Briefings or articles, please contact Antony Dine on +44 (0) 207 396 9315 or


The revolution in food and agricultural technology is only beginning

July 2017. By Daniel Green

In 2009, the UN-FAO released a report predicting that the worldÂ’s population would grow 34% by 2050. Among the many challenges posed by a growing world population, a primary challenge will be to ensure an adequate food supply for this vast population. This challenge is further complicated as the predominance of population growth will occur in regions of the world where food security issues are already rampant. The predicted increase in global demand for food has brought the agricultural and food production industries into the spotlight. As a global community, we will not only need to find ways to produce enough food to feed a growing world population, but we will need do so in a way that is sustainable and economically viable. [Continue Reading]

Back to index

Legal Developments by:
Yigal Arnon & Co

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada’s largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn’t quite told like that. We were fed terms such as “private keys,” lack of “multi-signature protection,” “cold storage wallets” and more readily understandable – “cryptofraud”. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the “Start-up Nation” and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on “fair, reasonable, and nondiscriminatory (“FRAND”) terms.”
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018